Access to experimental drugs for terminally ill patients
JAMA
.
2008 Dec 17;300(23):2793-5.
doi: 10.1001/jama.2008.828.
Authors
Benjamin P Falit
1
,
Cary P Gross
Affiliation
1
Section of General Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
PMID:
19088356
DOI:
10.1001/jama.2008.828
No abstract available
MeSH terms
Drug Industry
Drugs, Investigational*
Humans
Legislation, Drug*
Policy Making
Terminally Ill*
United States
United States Food and Drug Administration
Substances
Drugs, Investigational